Physician profile
Garrett D Locketz
NPI 1497119895
$1,167.62
in general payments reported to CMS, 2019-2025
11 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $137 · 2021: $162 · 2022: $153 · 2023: $454 · 2024: $148 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $330.38 | 2022-2025 | Dysport |
| Abbvie INC. | $260.23 | 2023 | |
| Allergan, INC. | $207.77 | 2020-2021 | |
| Medical Device Business Services, INC. | $137.42 | 2021-2022 | |
| Axonics, INC. | $61.32 | 2024 | Axonics, Bulkamid |
| Acclarent, INC | $58.57 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $30.70 | 2025 | Exparel |
| Ethicon US, LLC | $30.29 | 2025 | Stratafix, Ethicon, Surgiflo Hemostatic Matrix |
| Revance Therapeutics, INC. | $19.53 | 2024 | Daxxify |
| Intuitive Surgical, INC. | $15.78 | 2020 | |
| Mentor Worldwide LLC | $15.63 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Locketz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.